Tirzepatide Prescribing at MAPLE ACCESS PARTNERSHIP LLP

Drugs used in diabetes | Endocrine System

Items (12m)

140

Total Quantity

140

NHS Cost

£13.5K

vs National Avg

-27.9%

MAPLE ACCESS PARTNERSHIP LLP prescribed 140 items of Tirzepatide over the last 12 months at a cost of £13,527 to the NHS. This is 27.9% below the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.

Monthly Prescribing Trend

Jun 2026

Prescribing Details

Total Items	140
Total Quantity	140
Total NHS Cost	£13,527
Presentations	10 different forms
vs National Average	-27.9%

Tirzepatide Prescribing Comparison

This practice	140 items
National average per practice	194 items
Difference	-27.9% vs national average

Explore More

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.